Skip to main content
Top
Published in: Canadian Journal of Anesthesia/Journal canadien d'anesthésie 12/2010

01-12-2010 | Reports of Original Investigations

Off-label drug use in pediatric anesthesia and intensive care according to official and pediatric reference formularies

Authors: Dermot R. Doherty, MD, Elena Pascuet, MSc, Andy Ni, MSc, Paul Stewart, BScEng, William Splinter, MD, Régis Vaillancourt, PharmD

Published in: Canadian Journal of Anesthesia/Journal canadien d'anesthésie | Issue 12/2010

Login to get access

Abstract

Purpose

In pediatric practice, the official drug label often does not accurately reflect the contemporary use of many drugs prescribed to children. Therefore, clinicians frequently use contemporary drug references as a source of prescribing information instead of national formularies. The objective of this study was to compare drug prescriptions between two national formularies and two commnly used contemporary pediatric reference guidelines in the operating room/postanesthetic care unit (OR/PACU), pediatric intensive care unit (PICU), and neonatal intensive care unit (NICU).

Methods

We performed a retrospective chart review of patients admitted over a one-month period to the NICU and PICU, and for one week during the same month, we reviewed charts of patients in the OR/PACU. The data collected included patients’ demographic information, drugs prescribed, and dosage information. We assessed conformity with two national formularies, the Canadian Compendium of Pharmaceuticals and Specialties (CPS) and France’s 2009 Dictionnaire Vidal (Vidal), and two contemporary pediatric references, the Hospital for Sick Children Handbook and Formulary and the Lexi-Comp Pediatric Dosage Handbook.

Results

Across the three clinical units, 59.7% (95% confidence interval [CI] 57.1-62.1%) of prescriptions were identified as being off-label, as defined by the CPS formulary. The odds of having an off-label prescription would have been substantially lower if the contemporary pediatric references (odds ratio [OR] = 0.074; 95% CI 0.065-0.084) or Vidal (OR = 0.70; 95% CI 0.63-0.77) had been used to define the label (both P < 0.001 compared with the CPS).

Conclusion

Drugs are less likely to be off-label if prescribed according to a contemporary pediatric reference rather than according to national formularies. Methodologies used to compile contemporary references might serve as templates to inform a drug’s official label.
Footnotes
1
United States Congress. Best Pharmaceuticals for Children Act Pediatric Research Act 2007 Reauthorization. Improvements to Existing Law. Public Law (H.R. 3580):110-85.
 
2
European Union Regulation (EC) No. 1901/2006 of the European Parliament and of the Council of 12 December 2006 on medicinal product for paediatric use and amending Regulation (EEC) No 1768/92, Directive 2001/20/EC, Directive 2001/83/EC and Regulation (EC) no 726/2004.
 
Literature
1.
go back to reference ‘T Jong GW, Eland IA, Sturkenboom MC, van den Anker JN, Stricker BH. Unlicensed and off label prescription of drugs to children: population based cohort study. BMJ 2002; 324: 1313-4.CrossRefPubMed ‘T Jong GW, Eland IA, Sturkenboom MC, van den Anker JN, Stricker BH. Unlicensed and off label prescription of drugs to children: population based cohort study. BMJ 2002; 324: 1313-4.CrossRefPubMed
2.
go back to reference Carvalho PR, Carvalho CG, Alievi PT, Martinbiancho J, Trotta EA. Prescription of drugs not appropriate for children in a pediatric intensive care unit (Portuguese). J Pediatr (Rio J) 2003; 79: 397-402. Carvalho PR, Carvalho CG, Alievi PT, Martinbiancho J, Trotta EA. Prescription of drugs not appropriate for children in a pediatric intensive care unit (Portuguese). J Pediatr (Rio J) 2003; 79: 397-402.
3.
go back to reference Lindell-Osuagwu L, Korhonen MJ, Saano S, Helin-Tanninen M, Naaranlahti T, Kokki H. Off-label and unlicensed drug prescribing in three paediatric wards in Finland and review of the international literature. J Clin Pharm Ther 2009; 34: 277-87.CrossRefPubMed Lindell-Osuagwu L, Korhonen MJ, Saano S, Helin-Tanninen M, Naaranlahti T, Kokki H. Off-label and unlicensed drug prescribing in three paediatric wards in Finland and review of the international literature. J Clin Pharm Ther 2009; 34: 277-87.CrossRefPubMed
4.
go back to reference Pandolfini C, Bonati M. A literature review on off-label drug use in children. Eur J Pediatr 2005; 164: 552-8.CrossRefPubMed Pandolfini C, Bonati M. A literature review on off-label drug use in children. Eur J Pediatr 2005; 164: 552-8.CrossRefPubMed
6.
go back to reference Rodriguez W, Selen A, Avant D, et al. Improving pediatric dosing through pediatric initiatives: what we have learned. Pediatrics 2008; 121: 530-9.CrossRefPubMed Rodriguez W, Selen A, Avant D, et al. Improving pediatric dosing through pediatric initiatives: what we have learned. Pediatrics 2008; 121: 530-9.CrossRefPubMed
7.
go back to reference Canadian Pharmacists Association. (2009) Compendium of Pharmaceuticals and Specialties, 44 ed. Ottawa. Canadian Pharmacists Association. (2009) Compendium of Pharmaceuticals and Specialties, 44 ed. Ottawa.
8.
go back to reference O’Donnell CP, Stone RJ, Morley CJ. Unlicensed and off-label drug use in an Australian neonatal intensive care unit. Pediatrics 2002; 110: e52.CrossRefPubMed O’Donnell CP, Stone RJ, Morley CJ. Unlicensed and off-label drug use in an Australian neonatal intensive care unit. Pediatrics 2002; 110: e52.CrossRefPubMed
9.
go back to reference Barr J, Brenner-Zada G, Heiman E, et al. Unlicensed and off-label medication use in a neonatal intensive care unit: a prospective study. Am J Perinatol 2002; 19: 67-72.CrossRefPubMed Barr J, Brenner-Zada G, Heiman E, et al. Unlicensed and off-label medication use in a neonatal intensive care unit: a prospective study. Am J Perinatol 2002; 19: 67-72.CrossRefPubMed
10.
go back to reference Bavdekar SB, Sadawarte PA, Gogtay NJ, Jain SS, Jadhav S. Off-label drug use in a Pediatric Intensive Care Unit. Indian J Pediatr 2009; 76: 1113-8.CrossRefPubMed Bavdekar SB, Sadawarte PA, Gogtay NJ, Jain SS, Jadhav S. Off-label drug use in a Pediatric Intensive Care Unit. Indian J Pediatr 2009; 76: 1113-8.CrossRefPubMed
11.
go back to reference American Pharmacists Association. In: Taketomo CK, Hodding JH, Kraus DM, editors. Pediatric Dosage Handbook. 16th ed. OH, USA: Lexi-Comp, Inc; 2009. American Pharmacists Association. In: Taketomo CK, Hodding JH, Kraus DM, editors. Pediatric Dosage Handbook. 16th ed. OH, USA: Lexi-Comp, Inc; 2009.
12.
go back to reference 2008/09 Drug Handbook and Formulary (SickKids). The Hospital for Sick Children, Toronto, ON, Canada. Toronto: The Hospital for Sick Children. 2008/09 Drug Handbook and Formulary (SickKids). The Hospital for Sick Children, Toronto, ON, Canada. Toronto: The Hospital for Sick Children.
13.
go back to reference 2009 VIDAL Drug Compendium. Issy les Moulineaux, France: UBM Medica (Groupe United Business Media). 2009 VIDAL Drug Compendium. Issy les Moulineaux, France: UBM Medica (Groupe United Business Media).
14.
go back to reference Cuzzolin L, Atzei A, Fanos V. Off-label and unlicensed prescribing for newborns and children in different settings: a review of the literature and a consideration about drug safety. Expert Opin Drug Saf 2006; 5: 703-18.CrossRefPubMed Cuzzolin L, Atzei A, Fanos V. Off-label and unlicensed prescribing for newborns and children in different settings: a review of the literature and a consideration about drug safety. Expert Opin Drug Saf 2006; 5: 703-18.CrossRefPubMed
17.
go back to reference Anderson GD, Lynn AM. Optimizing pediatric dosing: a developmental pharmacologic approach. Pharmacotherapy 2009; 29: 680-90.CrossRefPubMed Anderson GD, Lynn AM. Optimizing pediatric dosing: a developmental pharmacologic approach. Pharmacotherapy 2009; 29: 680-90.CrossRefPubMed
18.
19.
go back to reference Aleksa K, Koren G. Ethical issues in including pediatric cancer patients in drug development trials. Paediatr Drugs 2002; 4: 257-65.PubMed Aleksa K, Koren G. Ethical issues in including pediatric cancer patients in drug development trials. Paediatr Drugs 2002; 4: 257-65.PubMed
20.
go back to reference Waisel DB. Moral responsibility to attain thorough pediatric drug labeling. Paediatr Anaesth 2009; 19: 989-93.CrossRefPubMed Waisel DB. Moral responsibility to attain thorough pediatric drug labeling. Paediatr Anaesth 2009; 19: 989-93.CrossRefPubMed
Metadata
Title
Off-label drug use in pediatric anesthesia and intensive care according to official and pediatric reference formularies
Authors
Dermot R. Doherty, MD
Elena Pascuet, MSc
Andy Ni, MSc
Paul Stewart, BScEng
William Splinter, MD
Régis Vaillancourt, PharmD
Publication date
01-12-2010
Publisher
Springer-Verlag
Published in
Canadian Journal of Anesthesia/Journal canadien d'anesthésie / Issue 12/2010
Print ISSN: 0832-610X
Electronic ISSN: 1496-8975
DOI
https://doi.org/10.1007/s12630-010-9395-0

Other articles of this Issue 12/2010

Canadian Journal of Anesthesia/Journal canadien d'anesthésie 12/2010 Go to the issue